Researchers seeking to improve treatment outcomes for women with recurrent endometrial cancer – the most commonly diagnosed gynecologic malignancy in the U.S., killing more than 8,000 women each year – have reported positive results through targeted therapy that uses a combination of the drugs everolimus and letrozole. Their findings have been reported in the Journal of Clinical Oncology.
The fifth annual Dolphins Cycling Challenge (DCC) takes place February 7 and 8. A festive kickoff will be held from 6 to 8 p.m. on Friday, February 6, at Sun Life Stadium.
Leading scientists from around the world presented their latest findings on cellular, molecular and genetic approaches to treating cancer at the Miami Winter Symposium 2015, "Towards Personalized Cancer Medicine," on January 18-21 at the Hyatt Regency Miami.
As director of special projects, Yolanda “Yoly” Hernandez, is passionate about raising funds for Sylvester Comprehensive Cancer Center. “Our team of experts discover, develop, and deliver the world’s most effective ways to prevent, detect, and treat cancer,” Hernandez says. “Funds raised for Sylvester stay in South Florida, guaranteeing that the day you or a loved one may need cancer treatment, you don’t need to go very far.”
Renowned pancreatic cancer clinician and scientist Nipun B. Merchant, M.D., is joining the Sylvester Comprehensive Cancer Center as Chief Surgical Officer and Director of Surgical Oncology Research Programs. Merchant comes to the University of Miami Miller School of Medicine and UHealth – University of Miami Health System from Vanderbilt University Medical Center.
A team of Miller School scientists has identified a compound that, when targeted to a location on the Hedgehog molecular signaling pathway, may prevent the recurrence of medulloblastoma, a type of brain tumor prevalent in children and adults.